Work

MPN-145 Retrospective Analysis of Anemia Benefit of Pacritinib From the PERSIST-2 Trial

Year: 2022

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)01439-2

Authors: Stephen Oh, Ruben Mesa, Claire Harrison, Prithviraj Bose, Aaron Gerds, Vikas Gupta, Ashwin Swami, Shanthakumar Tyavanagimatt, Sarah Buckley, Karisse Roman-Torres, Srdan Verstovsek

Institutions: Washington University in St. Louis, Mays Cancer Center at UT Health San Antonio, Guy's and St Thomas' NHS Foundation Trust, The University of Texas MD Anderson Cancer Center, Cleveland Clinic, University Health Network, Princess Margaret Cancer Centre, CTI BioPharma (United States)

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296529189

Cites:

Cited by: 9

Related to: 10